Graybug Vision Appoints Frédéric Guerard as Chief Executive Officer

Graybug Vision, Inc., a clinical stage pharmaceutical company developing potentially transformative therapies for ocular diseases, today announced that the Board of Directors has appointed Frédéric Guerard as Chief Executive Officer.

Mr. Guerard’s career in the pharmaceutical industry spans over 20 years and includes multiple leadership, strategic, and commercial roles. He joins from Novartis, where he was previously Worldwide Business Franchise Head of Ophthalmology. In this role, he successfully led the integration of Novartis retina and Alcon pharmaceuticals, and accelerated the rejuvenation of the product pipeline through strategic acquisitions and licensing transactions in dry-eye, presbyopia, and inherited retinal diseases. Prior to this role, he served as Global Franchise Head of Pharmaceuticals at Alcon. He has also held multiple leadership positions at Novartis, including Head of United Kingdom and Ireland, Head and Country President of Australia and New Zealand, Head of Marketing and Sales for Emerging Growth Markets Region, Head and Country President Egypt, and Cluster Head North and West Africa. He has served on the Board of the Association of the British Pharmaceutical Industry (ABPI) and on the Board of Medicines Australia. Mr. Guerard holds a PharmD and a Master of Biological and Medical Sciences from the University of Rouen, France and a Master of Marketing from HEC Paris.

Read more here.


Graybug Vision Presents Top Line Results of Phase 1/2a ADAGIO Study at Hawaiian Eye & Retina 2019

Graybug Vision, Inc., a clinical stage pharmaceutical company developing potentially transformative therapies for ocular diseases, today announced positive top line results for the ADAGIO study, a Phase 1/2a study of intravitreal GB-102 (sunitinib malate) in patients with wet age-related macular degeneration (AMD), the leading cause of blindness in the developed world for people age 50 and older. These data were presented by David S. Boyer, M.D., of Retina Vitreous Associates, Beverly Hills, CA, during a presentation of “New Developments in Drug Therapy for Retinal Disorders” at the 2019 Hawaiian Eye & Retina annual meeting in Kona, Hawaii.

Read more here.


Xometry Simplifies Custom Manufacturing Supply Chain, Launches Xometry Supplies

Xometry, the largest online marketplace for custom manufacturing, announced today the launch of Xometry Supplies. Xometry will help its 2,500 manufacturing partners simplify their supply chain by providing relevant materials, tools and industrial supplies when they accept jobs.

“Xometry Supplies is a natural extension of our efforts to provide our partners with both jobs and lower prices for their materials and tools,” said Xometry’s Co-Founder and CEO Randy Altschuler. “Ultimately our AI-driven algorithms will offer what our partners need when they need it, helping reduce not only cost but lead time. We will use these algorithms to make it easier and faster for manufacturers to get competitive pricing and fast delivery from one place, so they can focus on making high quality parts for customers.”

To support this new business line, Xometry has established a materials logistics hub in Lexington, KY and acquired Machine Tool & Supply of Jackson, TN, a leading regional tool supplier with 30+ years of operational experience to accelerate its go-to market effort for tooling and industrial supplies.

Read more here.


Pre-Sale Home Renovation Company Curbio Inc. Furthers Nationwide Expansion with Atlanta Launch

Curbio Inc., a rapidly expanding company that specializes in pre-sale home renovations, today announced that it will begin operations in the Atlanta metro area in February. The Maryland-based company will host a launch party for journalists and top producing listing agents at the rooftop of Atlanta’s Hotel Clermont from 4:30-6:30 pm on Thursday, January 17th.

Curbio focuses exclusively on preparing homes to be listed for sale. A full-service home improvement specialist, the company offers the complete spectrum of interior and exterior services. Venture-capital backed Curbio’s unique “Renovate Now, Pay When You Sell” model simplifies home selling by deferring all renovation costs until settlement.

“Everyone at Curbio is thrilled to have the opportunity to partner with Atlanta realtors to grow their businesses and deliver maximum ROI to their sellers,” said Rick Rudman, Curbio’s president and CEO. “As in the other markets we serve, Curbio looks forward to bringing hassle-free pre-sale home renovation to Atlanta realtors and their clients.”

Read more here.


How Tech Is Easing Returns for Retailers

Now that holiday gifts have been bought, given and received, retailers brace themselves for returns. It’s turning into a big problem, as many returned items never make it back to store shelves but to landfill. A number of companies are developing tech to tackle the issue. Bloomberg’s Emma Chandra speaks with Tobin Moore, chief executive officer of Optoro.

Watch the interview here.


Personal Genome Diagnostics and KingMed Enter Strategic Partnership to make Comprehensive Genomic Tissue Panel with TMB available in China and Hong Kong

Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, and KingMed Diagnostics, a laboratory services leader in China, announced today that they have entered into a strategic partnership for the PGDx elioTM tissue complete assay. KingMed Diagnostics brings substantial patient reach, encompassing 37 laboratories covering more than 21,000 hospitals and clinics. This partnership provides PGDx and KingMed Diagnostics the opportunity to serve the clinical trial screening needs of pharmaceutical partners in the Asian market through testing sites in mainland China and Hong Kong. In time and as a result of contributing data from these studies, the partners expect to also serve the clinical testing needs of patients and
physicians in those geographies upon the appropriate regulatory approvals of the PGDx elioTM assays.

The PGDx elio™ tissue complete panel is a 500+ gene test for somatic alterations that detects single nucleotide variants (SNVs), small insertion/deletions (indels), amplifications, rearrangements, microsatellite instability (MSI) and tumor mutational burden (TMB). The use of TMB and MSI for the identification of cancer patients whose tumors may be likely to respond to immune checkpoint inhibitor therapy has recently been investigated in clinical trials (TMB) and approved (MSI) by the U.S. Food and Drug Administration (FDA).

Read more here.


Blue Cross, Aledade team up to support independent practices in North Carolina through ACOs

A health plan and a startup company are pairing up to support independent primary care physicians in North Carolina.

Blue Cross and Blue Shield of North Carolina and Aledade, a well-funded startup that partners with primary care physicians to build and lead accountable care organizations (ACOs), are joining to launch a new initiative that will support hundreds of independently owned and operated primary care physician clinics in the state, according to an announcement Wednesday.

Doctors will be encouraged to join ACOs through which they can earn enhanced reimbursement rates and share in a portion of cost savings generated from the improved quality of care, the two organizations said.

Read more here.


iLearningEngines, Ranked Number 7 Fastest Growing Company in North America on Deloitte’s 2018 Technology Fast 500

Deloitte has announced that iLearningEngines ranked 7th on Deloitte’s Fast 500™, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies in North America. iLearningEngines also ranked #1 in the Greater Washington DC area for the second straight year. iLearningEngines previously ranked #14 as a Technology Fast 500™ award winner for 2017.

“iLearningEngines’ Learning and AI platform and its ability to drive desired outcomes at massive scale has strongly resonated with enterprises. Our growth rate continues to accelerate as enterprises are rapidly adopting iLearningEngines for mission-critical training,” said Harish Chidambaran, President and CEO.

“iLearningEngines is a category defining company that is transforming the way people learn and engage with expert content. iLearningEngines is well-positioned to continue its rapid growth globally. We are proud to be an investor in the business and partner with an exceptional Maryland based entrepreneur, Harish Chidambaran and his team,” said Parag Sheth, Director at the Maryland Venture Fund.

Read more here.


Shiji Completes Acquisition of StayNTouch

Shiji has today announced it has acquired StayNTouch, Inc. The addition of StayNTouch’s innovative and cloud-based hotel management tools to Shiji’s growing hotel technology stack will enable both StayNTouch and Shiji customers to seamlessly integrate across multiple hotels and travel technology systems.

Shiji is a leader in global hotel technology, at the core of all hotel and travel technology is the seamless and secure exchange of data across systems. Continuing the strategy of innovation through development or acquisitions and integrations. Shiji sees StayNTouch as an important part of making hotel management technology mobile and scalable for hotels of all sizes.

Read more here.